Skip to content

Clinical trials

Active, not recruiting Phase 2 Waldenstrom Macroglobulinemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Phase 2 Status: Active, not recruiting Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20141
20161
20171
20191
20201
20213
20221
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Christian Buske2
Dana-Farber Cancer Institute2
Shayna Sarosiek, MD2
AbbVie1
Acerta Pharma BV1
BeOne Medicines1
Cellectar Biosciences, Inc.1
City of Hope Medical Center1
M.D. Anderson Cancer Center1
Sunnybrook Health Sciences Centre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia14
Lymphoma, B-Cell, Marginal Zone5
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma3
Lymphoma, Mantle-Cell3
Neoplasms3
Lymphoma, Follicular2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Non-Hodgkin2
Multiple Myeloma2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.